FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing

Submitted by admin on August 16, 2021 - 11:08am

Source:

Fierce Biotech

News Tags:

Rocket Pharmaceuticals

gene therapy

FDA

Danon disease

Headline:

FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing

snippet:

Rocket Pharmaceuticals’ gene therapy trial is back on track. With the FDA lifting the clinical hold after Rocket changed the study protocol, the biotech is now on course to start dosing children in the third quarter.

Search form

You are here

FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing

FDA lifts clinical hold on Rocket gene therapy trial, creating launchpad for start of pediatric dosing